MedMen stock is continuing to tank in the aftermath of posting its quarterly results, which saw net loss more than double. Can MedMen Enterprises’ (CSE:MMEN) (OTCQX:MMNFF) push for recreational cannabis legislation in Flordia turn the fortunes of this pot stock around?
The Earnings DisappointmentLooking at MedMen’s earnings as a whole, Q4 fiscal 2019 technically wasn’t a terrible quarter for the US pot firm. Revenue of $42 million USD was a year-over-year increase of 104%, while the full-year figure of $130 million USD was a huge gain of 227% from 2018. However, MedMen stock tanked under ...
Read The Full Article On PotStockNews.com
Get the latest marijuana stock news, cannabis on stock news on PotStockNews
All content provided by Pot Stock News is subject to our Terms Of Use and Disclaimer.